Centre for Childhood Cancer Survivor Studies, School of Health and Population Sciences, Public Health Building, University of Birmingham, Edgbaston, Birmingham B15 2TT, England.
JAMA. 2010 Jul 14;304(2):172-9. doi: 10.1001/jama.2010.923.
Survivors of childhood cancer are at increased risk of premature mortality compared with the general population, but little is known about the long-term risks of specific causes of death, particularly beyond 25 years from diagnosis at ages when background mortality in the general population starts to increase substantially.
To investigate long-term cause-specific mortality among 5-year survivors of childhood cancer in a large-scale population-based cohort.
DESIGN, SETTING, AND PATIENTS: British Childhood Cancer Survivor Study, a population-based cohort of 17,981 5-year survivors of childhood cancer diagnosed with cancer before age 15 years between 1940 and 1991 in Britain and followed up until the end of 2006.
Cause-specific standardized mortality ratios (SMRs) and absolute excess risks (AERs).
Overall, 3049 deaths were observed, which was 11 times the number expected (SMR, 10.7; 95% confidence interval [CI], 10.3-11.1). The SMR declined with follow-up but was still 3-fold higher than expected (95% CI, 2.5-3.9) 45 years from diagnosis. The AER for deaths from recurrence declined from 97 extra deaths (95% CI, 92-101) per 10,000 person-years at 5 to 14 years from diagnosis, to 8 extra deaths (95% CI, 3-22) beyond 45 years from diagnosis. In contrast, during the same periods of follow-up, the AER for deaths from second primary cancers and circulatory causes increased from 8 extra deaths (95% CI, 7-10) and 2 extra deaths (95% CI, 2-3) to 58 extra deaths (95% CI, 38-90) and 29 extra deaths (95% CI, 16-56), respectively. Beyond 45 years from diagnosis, recurrence accounted for 7% of the excess number of deaths observed while second primary cancers and circulatory deaths together accounted for 77%.
Among a cohort of British survivors of childhood cancer, excess mortality from second primary cancers and circulatory diseases continued to occur beyond 25 years from diagnosis.
相较于普通人群,儿童癌症幸存者的过早死亡率更高,但对于具体死亡原因的长期风险知之甚少,尤其是在诊断后 25 年以上,此时普通人群的背景死亡率开始大幅上升。
在一项大型基于人群的队列研究中,调查儿童癌症 5 年幸存者的长期特定病因死亡率。
设计、地点和患者:英国儿童癌症幸存者研究,这是一项基于人群的队列研究,纳入了 1940 年至 1991 年间在英国诊断为 15 岁以下癌症的 17981 名 5 年幸存者,随访至 2006 年底。
病因特异性标准化死亡率比(SMR)和绝对超额风险(AER)。
共观察到 3049 例死亡,是预期数量的 11 倍(SMR,10.7;95%置信区间[CI],10.3-11.1)。随着随访时间的延长,SMR 有所下降,但在诊断后 45 年仍高出 3 倍(95%CI,2.5-3.9)。诊断后 5 至 14 年,复发导致的死亡 AER 从每 10000 人年 97 例超额死亡(95%CI,92-101)降至诊断后 45 年的 8 例超额死亡(95%CI,3-22)。相比之下,在同期随访中,第二原发癌和循环系统原因导致的死亡 AER 从 8 例超额死亡(95%CI,7-10)和 2 例超额死亡(95%CI,2-3)分别增加至 58 例超额死亡(95%CI,38-90)和 29 例超额死亡(95%CI,16-56)。在诊断后 45 年以上,复发导致的死亡占观察到的超额死亡人数的 7%,而第二原发癌和循环系统死亡占 77%。
在英国儿童癌症幸存者队列中,除了诊断后 25 年以上的第二原发癌和循环系统疾病导致的超额死亡继续发生外,还存在其他病因导致的超额死亡。